The Institutional Review Board (IRB) is a federally mandated committee responsible for overseeing research involving human participants. The mission of the IRB is to protect the rights and welfare of research participants. To do so, the IRB relies on the ethical principles identified in the Belmont Report (respect for persons, beneficence, non-maleficence and justice) when reviewing research projects, along with applicable federal regulations. The MetroHealth System IRB operates in compliance with Good Clinical Practice (GCP)/International Conference on Harmonization (ICH) Guidelines insofar as those guidelines are consistent with the U.S. Food and Drug Administration regulations (21 CFR Parts 50 and 56) and the Department of Health and Human Services regulations (45 CFR 46) pertaining to the protection of human subjects in research.
ACCREDITATION
Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) accreditation is a public affirmation of an organization's commitment to protecting research participants. The MetroHealth System Human Subjects Protection Program (HRPP) has full accreditation through AAHRPP since 2007 and recently awarded Full Reaccreditation in June 2025.
All users must have an electronic IRB (eIRB) account. To request an eIRB account, please click IRB User Access Requests (smartsheet.com)and submit the required information. Account registration is not an automatic process.
To log in, please click the "Login" button at the top-right of this page and follow the instructions.
To enhance the flexibility of our support and services, the IRB staff are available for consultations. During these sessions, you can meet one-on-one with IRB staff to ask questions, discuss upcoming projects (including regulatory guidance), or receive tailored advice for your specific IRB submission.
